References
- Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363–366
- Brantl S. Antisense-RNA regulation and RNA interference. Biochim Biophys Acta 2002; 1575: 15–25
- Cardoso ALC, Simoes S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, de Lima MCP. siRNA delivery by a transferrin-associated lipid-based vector: A non-viral strategy to mediate gene silencing. J Gene Med 2007; 9: 170–183
- Forrest LM, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem 2003; 14: 934–940
- Iwai M, Harada Y, Tanaka S, Muramatsu A, Mori T, Kashima K, Imanishi J, Mazda O. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector. Biochem Biophys Res Commun 2002; 291: 48–54
- Kumar VV, Singh RS, Chaudhuri A. Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr Med Chem 2003; 10: 1297–1306
- Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. Chitosan–DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004; 57: 1–8
- Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002; 110: 563–574
- Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: Implications for delivery of siRNA into mammalian cells. Nucleic Acids Res 2003; 31: 2717–2724
- Sun YX, Xiao W, Cheng SX, Zhang XZ, Zhuo RX. Synthesis of (Dex-HMDI)-g-PEIs as effective and low cytotoxic nonviral gene vectors. J Contr Rel 2008; 128: 171–178
- Wall NR, Shi Y. Small RNA: Can RNA interference be exploited for therapy?. Lancet 2003; 362: 1401–1403
- Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: Doublestranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25–33